Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 18.12
(3.13%)
CNY 18.12
(3.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.3 Billion CNY | -1.44% |
| 2022 | 14.51 Billion CNY | 20.82% |
| 2021 | 12.01 Billion CNY | 18.08% |
| 2020 | 10.17 Billion CNY | 12.66% |
| 2019 | 9.03 Billion CNY | 19.75% |
| 2018 | 7.54 Billion CNY | 5.86% |
| 2017 | 7.12 Billion CNY | 73.45% |
| 2016 | 4.1 Billion CNY | 142.53% |
| 2015 | 1.69 Billion CNY | 56.13% |
| 2014 | 1.08 Billion CNY | 28.55% |
| 2013 | 843.95 Million CNY | 36.83% |
| 2012 | 616.77 Million CNY | 48.59% |
| 2011 | 415.08 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 14.36 Billion CNY | -0.94% |
| 2024 Q1 | 14.4 Billion CNY | 0.67% |
| 2024 Q2 | 14.49 Billion CNY | 0.64% |
| 2023 Q3 | 14.56 Billion CNY | -1.79% |
| 2023 Q2 | 14.82 Billion CNY | 1.06% |
| 2023 Q1 | 14.67 Billion CNY | 1.07% |
| 2023 FY | 14.3 Billion CNY | -1.44% |
| 2023 Q4 | 14.3 Billion CNY | -1.75% |
| 2022 Q4 | 14.51 Billion CNY | 3.09% |
| 2022 Q2 | 13.38 Billion CNY | 7.12% |
| 2022 FY | 14.51 Billion CNY | 20.82% |
| 2022 Q1 | 12.49 Billion CNY | 3.98% |
| 2022 Q3 | 14.08 Billion CNY | 5.22% |
| 2021 FY | 12.01 Billion CNY | 18.08% |
| 2021 Q1 | 10.99 Billion CNY | 8.03% |
| 2021 Q2 | 11.52 Billion CNY | 4.79% |
| 2021 Q3 | 12.11 Billion CNY | 5.13% |
| 2021 Q4 | 12.01 Billion CNY | -0.79% |
| 2020 Q4 | 10.17 Billion CNY | 3.61% |
| 2020 Q1 | 8.98 Billion CNY | -0.56% |
| 2020 Q2 | 9.9 Billion CNY | 10.28% |
| 2020 FY | 10.17 Billion CNY | 12.66% |
| 2020 Q3 | 9.82 Billion CNY | -0.85% |
| 2019 Q4 | 9.03 Billion CNY | 5.17% |
| 2019 Q2 | 8.16 Billion CNY | 1.84% |
| 2019 Q3 | 8.58 Billion CNY | 5.14% |
| 2019 FY | 9.03 Billion CNY | 19.75% |
| 2019 Q1 | 8.02 Billion CNY | 6.34% |
| 2018 Q2 | 7.64 Billion CNY | 1.69% |
| 2018 FY | 7.54 Billion CNY | 5.86% |
| 2018 Q4 | 7.54 Billion CNY | 1.19% |
| 2018 Q3 | 7.45 Billion CNY | -2.5% |
| 2018 Q1 | 7.51 Billion CNY | 5.51% |
| 2017 Q2 | 4.67 Billion CNY | 3.1% |
| 2017 FY | 7.12 Billion CNY | 73.45% |
| 2017 Q1 | 4.53 Billion CNY | 10.31% |
| 2017 Q4 | 7.12 Billion CNY | 9.09% |
| 2017 Q3 | 6.53 Billion CNY | 39.82% |
| 2016 Q1 | 1.89 Billion CNY | 11.99% |
| 2016 Q4 | 4.1 Billion CNY | 54.99% |
| 2016 Q3 | 2.65 Billion CNY | 20.56% |
| 2016 Q2 | 2.19 Billion CNY | 15.9% |
| 2016 FY | 4.1 Billion CNY | 142.53% |
| 2015 FY | 1.69 Billion CNY | 56.13% |
| 2015 Q1 | 1.15 Billion CNY | 6.8% |
| 2015 Q2 | 1.59 Billion CNY | 37.55% |
| 2015 Q3 | 1.56 Billion CNY | -1.89% |
| 2015 Q4 | 1.69 Billion CNY | 8.34% |
| 2014 FY | 1.08 Billion CNY | 28.55% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | 985.98 Million CNY | 0.0% |
| 2014 Q4 | 1.08 Billion CNY | 0.0% |
| 2013 FY | 843.95 Million CNY | 36.83% |
| 2012 FY | 616.77 Million CNY | 48.59% |
| 2011 FY | 415.08 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 10.02 Billion CNY | -42.712% |
| WuXi AppTec Co., Ltd. | 74.26 Billion CNY | 80.731% |
| Autobio Diagnostics Co., Ltd. | 11.55 Billion CNY | -23.853% |
| Thalys Medical Technology Group Inc. | 3.34 Billion CNY | -328.214% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 11.76 Billion CNY | -21.604% |
| Chemclin Diagnostics Co., Ltd. | 1.82 Billion CNY | -686.02% |